A reduction in BDNF levels has been demonstrated in neonatal blood samples of autistic subjects and in numerous animal models of autism and genetic syndromes related to autistic behaviours (e.g., Rett syndrome), but also in patients affected by schizophrenia and depression [6,16,33,34,38,90]. Here, BDNF is linked to depressive symptom measurement.